CHAPTER 1 - MARKET SUMMARY
Market Overview
Vietnam Ophthalmology Market functions through a mixed care pathway in which optical retail clinics monetize recurrent refraction and eyewear demand, while hospitals and specialty centers capture higher-value surgery, diagnostics, and chronic treatment. The market handled about 52.8 Mn touchpoints in 2024 , and demand is anchored by refractive error, cataract, glaucoma, and diabetes-linked retinal disease. Commercially, this creates a broad entry base with clear upsell routes into lenses, imaging, procedures, and follow-up pharmaceuticals.
Ho Chi Minh City is the dominant commercial hub because it combines tertiary referral demand with the country’s deepest private ophthalmology cluster. Within the validated company universe used in this report, 4 of 10 leading providers are based in Ho Chi Minh City , including Ho Chi Minh City Eye Hospital, Saigon Eye Hospital, Cao Thang Eye Hospital, and Phuong Nam Eye Hospital. This concentration matters because premium surgery adoption, equipment placement, specialist recruitment, and medical tourism capture are strongest where provider density and purchasing power intersect.
CHAPTER 2 - SCOPE OF REPORT
Scope of the Market
CHAPTER 3 - Key Stakeholders
Key Target Audience
Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning.
Investors
CAGR, procedure mix, ARPU, capex intensity, reimbursement, import risk
Corporates
pricing power, channel control, technology depth, network expansion, margin
Government
access equity, blindness prevention, insurance coverage, digital screening, compliance
Operators
surgeon productivity, bed utilization, diagnostics uptime, patient conversion, procurement
Financial institutions
project finance, repayment visibility, collateral quality, demand durability
CHAPTER 4 - Market Size & Growth
Market Size, Growth Forecast and Trends
This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers.
Historical & Projected Market Size ($ Million)
Year-over-Year Growth Rate (%)
Market Value vs Volume Growth (%)
Historical Market Performance (2019-2024)
Vietnam Ophthalmology Market moved from USD 588 Mn in 2019 to USD 745 Mn in 2024 , but the path was uneven. The trough came in 2020 at USD 563 Mn , when elective procedures and in-person optical traffic were disrupted. Recovery accelerated from 2022 onward as patient activity rose from 40.6 Mn touchpoints in 2021 to 52.8 Mn in 2024 . Importantly, the revenue mix improved as ophthalmic surgical services rose to 19.5% of market revenue in 2024 , up from 17.0% in 2019 , indicating stronger monetization of higher-acuity care rather than a pure return to pre-pandemic traffic.
Forecast Market Outlook (2025-2030)
The 2025-2030 outlook is stronger than the historical period because mix is expected to upgrade alongside volume. Teleophthalmology and digital eye care are projected to expand from 2.7% of revenue in 2024 to 4.6% in 2030 , while patient and consumer touchpoints rise to roughly 72.1 Mn by 2030 . At the same time, the blended revenue per touchpoint improves from about USD 14.1 in 2024 to USD 14.8 in 2030 , supported by a higher share of premium surgery, diagnostics, anti-VEGF usage, and digitally enabled patient capture. This keeps growth structurally above the 2019-2024 pace even as mature eyewear pricing remains competitive.
CHAPTER 5 - Market Data
Market Breakdown
Vietnam Ophthalmology Market is shifting from a largely consultation- and refraction-led model toward a broader monetization stack that includes surgery, imaging, pharmaceuticals, lenses, and digital care. For CEOs and investors, the central issue is not only aggregate growth, but whether each operating model can convert patient flow into higher-value clinical and product revenue pools.
Year | Market Size (USD Mn) | YoY Growth (%) | Patient/Consumer Touchpoints (Mn) | Ophthalmic Surgical Services Share (%) | Teleophthalmology Revenue Share (%) | Period |
|---|---|---|---|---|---|---|
| 2019 | $588 Mn | +- | 41.0 | 17.0% | Forecast | |
| 2020 | $563 Mn | +-4.3% | 39.3 | 17.2% | Forecast | |
| 2021 | $579 Mn | +2.8% | 40.6 | 17.5% | Forecast | |
| 2022 | $637 Mn | +10.0% | 45.0 | 18.3% | Forecast | |
| 2023 | $692 Mn | +8.6% | 49.1 | 18.9% | Forecast | |
| 2024 | $745 Mn | +7.7% | 52.8 | 19.5% | Forecast | |
| 2025 | $791 Mn | +6.2% | 55.6 | 19.8% | Forecast | |
| 2026 | $840 Mn | +6.2% | 58.6 | 20.1% | Forecast | |
| 2027 | $892 Mn | +6.2% | 61.7 | 20.4% | Forecast | |
| 2028 | $947 Mn | +6.2% | 65.0 | 20.8% | Forecast | |
| 2029 | $1,005 Mn | +6.1% | 68.5 | 21.2% | Forecast | |
| 2030 | $1,067 Mn | +6.2% | 72.1 | 21.6% | Forecast |
Patient/Consumer Touchpoints
52.8 Mn, 2024, Vietnam . Scale supports multi-format delivery models across public hospitals, private surgery centers, and optical retail. Nearly 200 Mn insured treatment visits annually, 2024, Vietnam indicate that referral infrastructure is large enough to feed specialized eye-care conversion beyond major urban hubs. Source: Ministry of Health, 2024.
Ophthalmic Surgical Services Share
19.5%, 2024, Vietnam Ophthalmology Market . A rising surgery mix improves ASP, device pull-through, and physician productivity. Vietnam-Russia International Eye Hospital reported 25,000 ReLEx SMILE procedures, 2023, Vietnam , confirming a commercially meaningful premium refractive pool that supports higher-margin provider strategies. Source: Vietnam-Russia International Eye Hospital, 2023.
Teleophthalmology Revenue Share
2.7%, 2024, Vietnam Ophthalmology Market . The digital pool remains small but strategically important because it lowers rural acquisition cost and expands screening reach. Vietnam’s internet penetration reached 79.1%, 2024, Vietnam , and the 2G phase-out accelerated migration toward more capable devices for remote triage and follow-up. Source: DataReportal and MIC, 2024.
CHAPTER 6 - Segmentation
Market Segmentation Framework
Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns.
No of Segments
7
Dominant Segment
Disease Area
Fastest Growing Segment
Technology
Disease Area
Product Type
Care Setting
End User
Channel
Technology
Geography
Key Segmentation Takeaways
Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns.
Disease Area
Disease Area is the dominant segmentation lens because ophthalmology demand in Vietnam is strongly shaped by disease burden, treatment urgency, and care pathway economics. Cataract is the core revenue-driving sub-segment, supported by high procedure volumes, aging demographics, surgical device consumption, intraocular lens demand, and strong linkage between diagnosis, surgery, follow-up care, and hospital procurement.
Technology
Technology is the fastest-growing segmentation lens as providers upgrade diagnostic and surgical capabilities to improve outcomes, throughput, and early disease detection. Optical Coherence Tomography is the fastest-growing sub-segment, driven by expanding retina care, diabetic eye screening, private clinic investment, and increasing demand for advanced imaging to support premium clinical positioning.
CHAPTER 7 - Regional Analysis
Regional Analysis
Within a peer set of Indonesia, Thailand, the Philippines, and Malaysia, Vietnam Ophthalmology Market ranks in the middle tier by current size but above more mature ASEAN peers on forward growth. Its position is supported by a combination of rising ageing exposure, strong insurance participation, and better digital readiness than its historical healthcare base would suggest.
Regional Ranking
3rd
Vietnam Market Size (2024)
USD 745 Mn
Vietnam CAGR (2025-2030)
6.2%
Regional Ranking
3rd
Vietnam Market Size (2024)
USD 745 Mn
Vietnam CAGR (2025-2030)
6.2%
Regional Analysis (Current Year)
Market Position
Vietnam ranks 3rd among selected ASEAN peers with a USD 745 Mn market in 2024, ahead of Malaysia and the Philippines on current scale because its organized hospital and optical channels are deeper.
Growth Advantage
Vietnam’s 6.2% forecast CAGR sits above Thailand’s 4.9% and Malaysia’s 5.1% , positioning it as a regional growth challenger rather than a mature replacement market.
Competitive Strengths
Vietnam combines 79.1% internet penetration , nearly 94 Mn insured citizens , and strong private refractive surgery adoption, giving providers a better base for hybrid clinical and digital expansion.
CHAPTER 8 - INDUSTRY ANALYSIS
Growth Drivers, Market Challenges & Market Opportunities
Comprehensive analysis of key factors shaping the Vietnam Ophthalmology Market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments.
Growth Drivers
Ageing and disease burden widen the addressable treatment pool
- The market processed 52.8 Mn touchpoints (2024, Vietnam Ophthalmology Market) , showing that eye care is not a narrow tertiary niche but a high-frequency care category with multiple monetization points across consultations, devices, lenses, surgery, and pharmaceuticals.
- WHO identifies cataract and refractive error as leading causes of vision impairment, which aligns with Vietnam’s disease mix and keeps both mass-market correction and higher-value surgical pathways economically relevant.
- Health insurance participation reached 93.937 Mn people (10M 2024, Vietnam) , improving conversion for medically necessary eye care and supporting steadier volume in cataract, glaucoma, and diabetic retinal pathways.
Private-capital technology upgrading is lifting revenue per patient
- Saigon Eye Hospital launched personalized myopia correction technology in 2025 (Saigon Eye Hospital, Vietnam) , showing that private operators are using technology differentiation to command pricing premiums and attract urban self-pay patients.
- Cao Thang Eye Hospital’s repeated JCI track record and global association recognition indicate that premium ophthalmology care is building institutional credibility, which matters for referrals, expatriate demand, and higher-margin elective procedures.
- As surgical services already account for 19.5% of market revenue (2024, Vietnam Ophthalmology Market) , each additional technology upgrade has a multiplier effect across diagnostics, consumables, IOLs, surgeon productivity, and post-operative pharmaceuticals.
Digital infrastructure is improving access economics outside core cities
- Vietnam’s telemedicine program was institutionalized under Decision 2628/QD-BYT (2020, Vietnam) , creating a formal basis for remote consultation, hospital-to-hospital support, and triage extension into underserved provincial corridors.
- More than 10 Mn 2G users (2024, Vietnam) were required to transition as legacy networks were phased out, increasing the reachable installed base for app-based booking, follow-up reminders, and remote screening workflows.
- Because teleophthalmology is the fastest-growing segment at 18.5% CAGR (2024-2029, Vietnam Ophthalmology Market) , early movers can build low-capex patient acquisition layers before provincial provider competition becomes crowded.
Market Challenges
Import dependence keeps costs, availability, and margins exposed
- Import reliance raises landed-cost sensitivity for phaco systems, OCT, premium IOLs, and retinal consumables, compressing distributor and hospital margins when FX or logistics costs move unfavorably.
- Central Eye Hospital publicly faced supply shortages in January 2024 (Vietnam) , highlighting how procurement disruptions can delay surgeries and directly reduce revenue conversion in high-acuity service lines.
- For investors, the implication is clear: returns depend not only on patient demand, but on channel control, vendor relationships, inventory discipline, and the ability to secure premium consumables without service interruption.
Provider concentration limits national access consistency
- Within the validated competitive universe in this report, Hanoi and Ho Chi Minh City account for 8 of 10 profiled providers (2024, Vietnam) , indicating that organized supply is still heavily metro-centric.
- Da Nang Eye Hospital reports 180 beds and 150 employees (Vietnam) , which is meaningful regionally but still underscores how provincial access depends on relatively few specialized institutions.
- For operators, unequal access raises referral leakage and increases the commercial value of hub-and-spoke models, visiting specialist programs, and remote diagnostics attached to metropolitan surgery centers.
Mass vision correction faces pricing pressure and channel dilution
- High digital penetration at 79.1% internet use (2024, Vietnam) increases price transparency for frames and lenses, pushing consumers toward comparison shopping and limiting same-store gross margin protection.
- Because uncorrected refractive error remains the leading cause of vision impairment globally, correction demand is resilient, but monetization shifts toward efficient chains with procurement scale rather than fragmented independent sellers.
- This forces optical operators to compete on lens mix, branded experience, exams, and financing rather than relying on simple volume growth or frame mark-up alone.
Market Opportunities
Provincial tele-screening can unlock new referral and chronic care revenue
- tele-screening, AI-assisted grading, and specialist review can create fee-based referral funnels for diabetic retinopathy, glaucoma follow-up, and post-operative monitoring with limited upfront real estate investment.
- private hospital groups, imaging vendors, and insurer-linked networks can use digital triage to fill urban surgical capacity with provincially sourced patients and repeat follow-up revenue.
- provincial screening workflows need standard referral protocols, connected imaging devices, and reimbursement clarity for remote consult components to scale sustainably.
Premium cataract and refractive surgery can expand the high-margin pool
- premium IOLs, bladeless phaco, personalized refractive correction, and branded surgical pathways carry materially higher ASP and stronger cross-sell into diagnostics and pharmaceuticals.
- hospital groups with surgeon brands, imported equipment access, and urban middle-income patient flow are best placed to capture this revenue mix improvement.
- operators need structured financing options, strong outcomes communication, and premium product procurement reliability so elective conversion does not stall at the point of counseling.
Local distribution and light-assembly partnerships can capture import-heavy value pools
- distributors can move up the stack from simple import resale into service contracts, training, calibration, inventory planning, and localized kitting for surgical centers.
- international manufacturers seeking market depth, local healthcare investors building national sales networks, and private hospitals wanting stronger supply assurance all gain from tighter channel integration.
- scalable opportunity requires disciplined registration, after-sales engineering capability, and purchasing agreements that tie equipment placements to recurring consumable and procedure volumes.
CHAPTER 9 - Competitive Landscape
Competitive Landscape Overview
Competition is fragmented across public referral hospitals, private eye hospital chains, and specialty centers. Entry barriers are moderate to high because technology investment, surgeon reputation, regulatory compliance, and referral relationships matter more than simple geographic presence.
Market Share Distribution
Top 5 Players
Market Dynamics
8 new entrants in the past 5 years, indicating strong market attractiveness and growth potential.
Company Name | Market Share | Headquarters | Founding Year | Core Market Focus |
|---|---|---|---|---|
Ho Chi Minh City Eye Hospital | - | Ho Chi Minh City, Vietnam | 1978 | Public tertiary ophthalmology care, cataract, retina, cornea, glaucoma |
Central Eye Hospital | - | Hanoi, Vietnam | 1957 | National referral ophthalmology, complex surgery, training and research |
Saigon Eye Hospital | - | Ho Chi Minh City, Vietnam | 2004 | Private ophthalmology chain, refractive surgery, cataract, premium diagnostics |
Da Nang Eye Hospital | - | Da Nang, Vietnam | - | Regional public eye care, cataract services, community ophthalmology |
Vietnam- Russia International Eye Hospital | - | - | 2007 | Refractive surgery, premium cataract, advanced surgical technology |
Hanoi High Tech Eye Hospital | - | Hanoi, Vietnam | 2000 | Private eye hospital, cataract surgery, refraction and outpatient care |
DND International Eye Hospital | - | Hanoi, Vietnam | - | Comprehensive private ophthalmology, diagnostics, surgery, patient-centered care |
Cao Thang Eye Hospital | - | Ho Chi Minh City, Vietnam | 2001 | Premium cataract, refractive surgery, international-standard eye care |
Phuong Nam Eye Hospital | - | Ho Chi Minh City, Vietnam | 2013 | Cataract, refraction, outpatient surgery, advanced ophthalmic care |
Japan International Eye Hospital | - | Hanoi, Vietnam | 2014 | Japanese-standard ophthalmology, cataract, diagnostics, specialist eye care |
Cross Comparison Parameters
The report provides detailed cross-comparison of key players across 10 performance parameters to identify competitive strengths and weaknesses.
Service Breadth
Surgical Technology Depth
Diagnostic Platform Depth
Geographic Network Reach
Doctor Brand Equity
Procedure Mix Quality
Quality Accreditation
Digital Patient Engagement
Insurance and Payment Integration
Procurement Resilience
Analysis Covered
Market Share Analysis:
Assesses player positioning, service breadth, and organized market concentration trends.
Cross Comparison Matrix:
Benchmarks hospitals on technology, network reach, specialization, and execution discipline.
SWOT Analysis:
Highlights competitive moats, referral strength, vulnerabilities, and investment readiness levels.
Pricing Strategy Analysis:
Compares premium surgery pricing, reimbursement exposure, and mass-market accessibility tradeoffs.
Company Profiles:
Summarizes ownership, location, founding history, and core ophthalmology focus areas.
CHAPTER 10 - REPORT TOC
Market Report Structure
Comprehensive coverage across three strategic phases — Market Assessment, Go-To-Market Strategy, and Survey — delivering end-to-end insights from market analysis and execution roadmap to customer demand validation.
Phase 1Market Assessment Phase
11
Chapters
Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts.
Phase 2Go-To-Market Strategy Phase
15
Chapters
Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook.
Complete Report Coverage
201+ detailed sections covering every aspect of the market
143
Assessment Sections
58
Strategy Sections
CHAPTER 11 - Our Approach
Research Methodology
Desk Research
- Hospital licensing and capacity mapping
- Ophthalmic device import review
- Refractive surgery pricing benchmarks
- Insurance and reimbursement analysis
Primary Research
- Medical directors of eye hospitals
- Senior ophthalmic surgeons interviewed
- Optical chain procurement leaders
- Distributor country managers engaged
Validation and Triangulation
- 310 respondent cross-check sample
- Revenue-volume-ASP reconciliation loops
- Public-private channel share testing
- Procedure mix consistency screening
CHAPTER 12 - FAQ
FAQs
Still have questions?
Our research team is here to help you find the right solution
CHAPTER 13 - Related Research
Explore Related Reports
Expand your market intelligence with complementary research across regions and adjacent markets.
Regional/Country ReportsRelated market analysis across key regions
Related market analysis across key regions
Adjacent ReportsRelated markets and complementary research
Related markets and complementary research
500+
Market Research Reports
50+
Countries Covered
15+
Industry Verticals